Lamprene

Active Ingredient(s): Clofazimine
FDA Approved: * December 15, 1986
Pharm Company: * NOVARTIS
Category: Leprosy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lamprene Overview

Clofazimine, sold under the brand name Lamprene, is a medication used together with rifampicin and dapsone to treat leprosy.[1] It is specifically used for multibacillary (MB) leprosy and erythema nodosum leprosum.[2] Evidence is insufficient to support its use in other conditions[1] though a retrospective study found it 95% effective in the treatment of Mycobacterium avium complex (MAC) when administered with a macrolide and ethambutol,[...

Read more Lamprene Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Clofazimine

Recent Lamprene Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Clofazimine
  • Capsule: 100mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Clofazimine or a similar ingredient: (1 result)